Skip to main content
logo
Creo Medical Group PLC (AIM:CREO)
London flag London · Delayed Price · Currency is GBP · Price in GBX
14.30
-0.20 (-1.38%)
May 28, 2026, 4:14 PM GMT

Creo Medical Group Income Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
64427.225.16
Revenue
64427.225.16
Revenue Growth (YoY)
50.00%--85.29%8.10%166.85%
Cost of Revenue
3.62.11.71413.58
Gross Profit
2.41.92.313.211.59
Selling, General & Admin
23.129.229.14441.54
Other Operating Expenses
-1.20.4-0.4-0.1-0.05
Operating Expenses
21.929.628.743.941.49
Operating Income
-19.5-27.7-26.4-30.7-29.91
Interest Expense
-0.3-0.4-0.2-0.2-0.21
Interest & Investment Income
-0.20.70.10.03
Earnings From Equity Investments
1.7----
Other Non Operating Income (Expenses)
0.6---0.1-0.25
EBT Excluding Unusual Items
-17.5-27.9-25.9-30.9-30.34
Merger & Restructuring Charges
--1.1---
Other Unusual Items
---0.5--
Pretax Income
-17.5-29-26.4-30.9-30.34
Income Tax Expense
--1.2-2.7-4-5.74
Earnings From Continuing Operations
-17.5-27.8-23.7-26.9-24.6
Earnings From Discontinued Operations
22.8-0.92--
Net Income
5.3-28.7-21.7-26.9-24.6
Net Income to Common
5.3-28.7-21.7-26.9-24.6
Shares Outstanding (Basic)
530370313181164
Shares Outstanding (Diluted)
530370313181164
Shares Change (YoY)
43.25%18.20%72.61%10.28%5.54%
EPS (Basic)
0.01-0.08-0.07-0.15-0.15
EPS (Diluted)
0.01-0.08-0.07-0.15-0.15
Free Cash Flow
-19.1-22.5-22.8-28.1-31.99
Free Cash Flow Per Share
-0.04-0.06-0.07-0.15-0.20
Gross Margin
40.00%47.50%57.50%48.53%46.04%
Operating Margin
-325.00%-692.50%-660.00%-112.87%-118.86%
Profit Margin
88.33%-717.50%-542.50%-98.90%-97.75%
Free Cash Flow Margin
-318.33%-562.50%-570.00%-103.31%-127.13%
EBITDA
-18.5-26.7-24.7-28.5-28.15
EBITDA Margin
----104.78%-111.88%
D&A For EBITDA
111.72.21.76
EBIT
-19.5-27.7-26.4-30.7-29.91
EBIT Margin
----112.87%-118.86%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.